IS7894A - Skammtaform með ofnæmisvaka - Google Patents

Skammtaform með ofnæmisvaka

Info

Publication number
IS7894A
IS7894A IS7894A IS7894A IS7894A IS 7894 A IS7894 A IS 7894A IS 7894 A IS7894 A IS 7894A IS 7894 A IS7894 A IS 7894A IS 7894 A IS7894 A IS 7894A
Authority
IS
Iceland
Prior art keywords
allergy
dosage form
dosage
Prior art date
Application number
IS7894A
Other languages
English (en)
Inventor
Hugo Jacobi Henrik
Rømmelmayer Annette
Gauguin Houghton Christian
Aasmul-Olsen Stig
Lund Maerkedahl Lise
Søndergaard Andersen Jan
Original Assignee
Alk-Abello A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk-Abello A/S filed Critical Alk-Abello A/S
Publication of IS7894A publication Critical patent/IS7894A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035—Blister-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/325—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil
    • B65D75/327—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet being recessed, and the other being a flat not- rigid sheet, e.g. puncturable or peelable foil and forming several compartments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Mechanical Engineering (AREA)
  • Composite Materials (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
IS7894A 2002-11-26 2005-06-14 Skammtaform með ofnæmisvaka IS7894A (is)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42908602P 2002-11-26 2002-11-26
DKPA200201825 2002-11-26
DKPA200300279 2003-02-24
PCT/DK2003/000814 WO2004047794A2 (en) 2002-11-26 2003-11-26 An allergen dosage form

Publications (1)

Publication Number Publication Date
IS7894A true IS7894A (is) 2005-06-14

Family

ID=32397517

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7894A IS7894A (is) 2002-11-26 2005-06-14 Skammtaform með ofnæmisvaka

Country Status (16)

Country Link
US (6) US20040166123A1 (is)
EP (2) EP2436395B1 (is)
JP (2) JP5442924B2 (is)
KR (2) KR101281147B1 (is)
CN (1) CN101816787A (is)
AU (3) AU2003280324A1 (is)
BR (1) BR0316564A (is)
CA (1) CA2507551A1 (is)
CO (1) CO5690534A2 (is)
IL (1) IL168733A (is)
IS (1) IS7894A (is)
MX (2) MXPA05005528A (is)
NO (1) NO20053142L (is)
NZ (1) NZ540850A (is)
PL (1) PL218350B1 (is)
WO (2) WO2004047793A1 (is)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2116257T3 (da) 2000-08-09 2013-02-04 Alk Abello As Parenterale vaccineformuleringer og anvendelser deraf
US7927600B2 (en) * 2001-03-30 2011-04-19 Emile Loria Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
CA2554337A1 (en) * 2004-02-06 2005-08-25 Greer Laboratories, Inc. Methods and compositions for dosing of allergens
US20060115499A1 (en) * 2004-09-27 2006-06-01 Alk-Abello A/S Liquid allergy vaccine formulation for oromucosal administration
ES2317313T3 (es) * 2004-10-19 2009-04-16 Krka, Tovarna Zdravil, D.D., Novo Mesto Composicion farmaceutica solida que comprende clorhidrato de donepezilo.
WO2006050729A2 (en) * 2004-11-10 2006-05-18 Alk-Abellò A/S Method of preventive treatment of allergy by mucosal administration of an allergy vaccine
US20060210590A1 (en) * 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
ZA200707413B (en) 2005-03-18 2009-01-28 Cytos Biotechnology Ag Cat allergen fusion proteins and uses thereof
AU2006299310A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
CN103933562A (zh) * 2005-11-04 2014-07-23 爱尔开-阿贝优公司 用于口腔粘膜给药的液体变态反应性疫苗制剂的用途
EP1814516B1 (en) * 2005-11-04 2012-12-26 Alk-Abelló A/S Use of a liquid allergy vaccine formulation for oromucosal administration
CN101361000B (zh) 2005-12-23 2013-04-17 爱尔开-阿贝优公司 用于药用产品溶出试验的方法
EP1872792A1 (en) * 2006-06-29 2008-01-02 Biotech Tools S.A. A method for the production of hydrolyzed allergen
CN101678012A (zh) * 2007-06-12 2010-03-24 阿尔克-阿贝洛有限公司 包含抗组胺药的过敏原剂型
GB0711683D0 (en) * 2007-06-16 2007-07-25 Enigma Diagnostics Ltd Compositions
EP2187926B1 (en) 2007-09-11 2012-01-25 Københavns Universitet Prevention of diabetes by administration of gliadin
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010086989A1 (ja) 2009-01-29 2010-08-05 日東電工株式会社 口腔内フィルム状基剤及び製剤
JP5588688B2 (ja) 2010-01-28 2014-09-10 日東電工株式会社 フィルム状製剤
WO2011112788A1 (en) * 2010-03-12 2011-09-15 Antigen Laboratories, Inc. Methods of treating allergies with substantially phenol-free carriers
JP5751868B2 (ja) 2010-03-30 2015-07-22 日東電工株式会社 フィルム状製剤及びその製造方法
JP5800527B2 (ja) * 2010-03-30 2015-10-28 日東電工株式会社 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法
EP2563390A4 (en) * 2010-04-30 2014-05-14 Allovate Llc METHOD AND ARTICLE FOR PREVENTING OR REDUCING THE RISK OF DEVELOPING A HYPERALGENIC IMMUNE SYSTEM
JP6062851B2 (ja) * 2010-04-30 2017-01-18 アロヴェイト・エルエルシー 口腔粘膜を介してアレルギーを減感作するための方法、物品及びキット
BR122021008456B1 (pt) * 2010-06-03 2021-08-03 Alk-Abelló A/S Métodos de fabricação de um extrato de alérgenos de ácaro de pó doméstico
EP2575832B1 (en) * 2010-06-03 2017-07-26 ALK-Abelló A/S Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof
HUE052853T2 (hu) 2010-10-08 2021-05-28 Scherer Technologies Llc R P Orális vakcina gyorsan oldódó dózisforma, keményítõ alkalmazásával
JP5875246B2 (ja) * 2010-12-10 2016-03-02 日東電工株式会社 シート状製剤及びシート状製剤の製造方法
JP5555148B2 (ja) * 2010-12-10 2014-07-23 日東電工株式会社 シート状製剤及びシート状製剤の製造方法
GB201104537D0 (en) * 2011-03-17 2011-05-04 Cambridge Entpr Ltd Treatment for peanut allergy
FI20115375A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
FI20115374A0 (fi) 2011-04-18 2011-04-18 Teknologian Tutkimuskeskus Vtt Oy Uudet hypoallergeenit
JP5952634B2 (ja) * 2011-05-20 2016-07-13 日東電工株式会社 医薬組成物およびその製造方法
EP2524701A3 (en) 2011-05-20 2012-12-19 Nitto Denko Corporation Pharmaceutical composition and method for producing the same
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
JP5841433B2 (ja) 2012-01-11 2016-01-13 日東電工株式会社 口腔内フィルム状基剤及び製剤
MX2014009285A (es) * 2012-02-07 2015-02-04 Jolla Inst Allergy Immunolog Alergenos del fleo de los prados y metodos y usos para la modulacion de respuesta inmune.
WO2013173697A1 (en) * 2012-05-17 2013-11-21 The Johns Hopkins University Orally dissolving thin films containing allergens and methods of making and use
JP2014034530A (ja) * 2012-08-07 2014-02-24 Nitto Denko Corp アレルゲン含有シート状製剤及びその製造方法
US9574004B2 (en) 2012-08-21 2017-02-21 Sanofi Biotechnology Methods for treating or preventing asthma by administering an IL-4R antagonist
PT3889181T (pt) 2012-09-07 2024-05-29 Regeneron Pharma Um anticorpo antagonista de il-4r para utilização no tratamento da dermatite atópica por administração
CN103215236A (zh) * 2013-01-29 2013-07-24 中国科学院昆明动物研究所 尘螨过敏原Derf8和Derf20及其基因和应用
WO2014159609A1 (en) 2013-03-14 2014-10-02 Allergen Research Corporation Peanut formulations and uses thereof
ES2503516B1 (es) * 2013-04-03 2015-09-09 Inmunotek, S.L. Complejo inmunogénico para vacunación y método de obtención
TWI633891B (zh) 2013-06-04 2018-09-01 再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法
KR102385900B1 (ko) 2013-09-19 2022-04-11 알로베이트, 엘엘씨 구강점막으로 알레르겐을 전달하기 위한 치약
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
WO2016042372A1 (en) 2014-09-17 2016-03-24 Steer Engineering Private Limited Effervescent composition and method of making it
AU2015346150B2 (en) 2014-11-14 2021-08-19 Regeneron Pharmaceuticals, Inc. Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
KR101878414B1 (ko) * 2016-08-12 2018-07-13 연세대학교 산학협력단 마이크로니들 패치, 이의 제조방법 및 이를 이용한 알레르기 질환 진단방법
HUE067888T2 (hu) 2016-09-01 2024-11-28 Regeneron Pharma Módszerek az allergia megelõzésére vagy kezelésére egy IL-4R antagonista adagolásával
WO2018057776A1 (en) 2016-09-22 2018-03-29 Regeneron Pharmaceuticals, Inc. Methods for treating severe atopic dermatitis by administering an il-4r inhibitor
US10359292B2 (en) 2017-04-05 2019-07-23 International Business Machines Corporation Deep learning allergen mapping
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
US11524019B2 (en) 2017-08-21 2022-12-13 Glycom A/S Synthetic composition for reducing allergy symptoms
CA3079946A1 (en) 2017-10-30 2019-05-09 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
FI128016B (en) 2018-01-04 2019-07-31 Desentum Oy Recombinant hypoallergenic Ecu c1 polypeptides for use in horse allergy immunotherapy
EP3829632A4 (en) * 2018-07-27 2022-05-04 Société des Produits Nestlé S.A. SYSTEMS AND METHODS FOR DELIVERING UNIT DOSES OF ORAL IMMUNOTHERAPY
US20210315865A1 (en) * 2018-08-16 2021-10-14 Biohaven Therapeutics Ltd. Use of riluzole oral disintigrating tablets for treating diseases
US12433945B2 (en) 2018-08-16 2025-10-07 Société des Produits Nestlé S.A. Peanut oral immunotherapy with maintenance dose
JP7496356B2 (ja) * 2018-11-30 2024-06-06 ジェネンテック， インコーポレイテッド 凍結乾燥薬剤内の夾雑物を同定するためのレーザー誘起破壊分光法
US12226448B2 (en) 2018-12-20 2025-02-18 Société des Produits Nestlé S.A. Peanut oral immunotherapy dosing schedule for missed doses
CA3132587A1 (en) 2019-03-21 2020-09-24 Regeneron Pharmaceuticals, Inc. Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy
CA3137295A1 (en) 2019-05-10 2020-11-19 Aimmune Therapeutics, Inc. Methods for improving the quality of life of a patient with a peanut allergy
BR112022000740A2 (pt) 2019-07-16 2022-07-05 Sanofi Biotechnology Métodos para tratamento ou prevenção de asma por administração de um antagonista de il-4r
US11504426B2 (en) 2019-08-05 2022-11-22 Regeneron Pharmaceuticals, Inc. Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
WO2021026205A1 (en) 2019-08-05 2021-02-11 Regeneron Pharmaceuticals, Inc. Methods for treating atopic dermatitis by administering an il-4r antagonist
JP7050734B2 (ja) * 2019-09-30 2022-04-08 鳥居薬品株式会社 舌下アレルゲン免疫療法におけるフィルム製剤
CN114053402A (zh) * 2020-08-03 2022-02-18 格林生物医药科技(天津)有限公司 一种过敏原制剂
WO2022103639A1 (en) 2020-11-16 2022-05-19 Orcosa Inc. Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs
US11672761B2 (en) 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
CN117530926A (zh) * 2022-08-02 2024-02-09 江苏众红生物工程创药研究院有限公司 一种舌下片及其在脱敏治疗药物中的应用
WO2024256749A1 (en) 2023-06-12 2024-12-19 Desentum Oy Hypoallergenic variants of major peanut allergen, ara h 2

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US107208A (en) * 1870-09-06 Improvement in apparatus for the manufacture of illuminating-gas
US271079A (en) * 1883-01-23 Grain weigher and tally
US44351A (en) * 1864-09-20 Gang-plow
US278877A (en) * 1883-06-05 Ribbon or label holder for hats
US346622A (en) * 1886-08-03 Bedstead
US57856A (en) * 1866-09-11 Improvement in cultivators
US2378383A (en) * 1942-10-17 1945-06-19 Brush Dev Co Transient signal recordingreproducing device
US3816314A (en) * 1972-05-31 1974-06-11 Exxon Research Engineering Co Block copolymers of unsaturated ester and a nitrogen containing monomer as v.i.improving and dispersant additives for oils
DD107208A1 (is) 1973-06-04 1974-07-20
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4371513A (en) * 1977-03-25 1983-02-01 W. R. Grace & Co. Alumina compositions
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
US4822611A (en) 1986-12-09 1989-04-18 Immunotec, Inc. Oral hyposensitization in the treatment of allergies
FR2609895B1 (fr) 1987-01-28 1991-06-28 Bruttmann Georges Nouvelles formes galeniques d'allergenes pour administration par voie per- et sub-linguale
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
IT1217628B (it) * 1988-05-18 1990-03-30 Neo Abello Spa Forma farmaceutica e supporto per la somministrazione di estratti ellergenici
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
JPH0537070A (ja) 1991-07-26 1993-02-12 Sharp Corp 分布帰還型半導体レーザ素子の製造方法
JPH0597672A (ja) * 1991-10-08 1993-04-20 Terumo Corp アミド誘導体含有固形製剤およびその製造方法
AU3949093A (en) * 1992-03-31 1993-11-08 Benzon Pharma A/S A pharmaceutical formulation
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage form comprising a porous network of matrix forming material which disperses rapidly in water
US5343762A (en) 1992-10-05 1994-09-06 Rosemount Inc. Vortex flowmeter
US5343672A (en) * 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
US5762961A (en) * 1996-02-09 1998-06-09 Quadrant Holdings Cambridge Ltd. Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
US6074673A (en) 1996-04-22 2000-06-13 Guillen; Manuel Slow-release, self-absorbing, drug delivery system
JP2832885B2 (ja) 1996-09-02 1998-12-09 株式会社林原生物化学研究所 スギ花粉アレルゲン
JP4218987B2 (ja) 1996-11-13 2009-02-04 明治乳業株式会社 ペプチド免疫療法治療剤
WO1998036738A1 (en) * 1997-02-20 1998-08-27 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
DE19713001A1 (de) * 1997-03-27 1998-10-01 Merck Patent Gmbh Graminaenpollenallergenmutanten zur spezifischen Immuntherapie, deren Herstellung und Verwendung
GB9722682D0 (en) 1997-10-27 1997-12-24 Scherer Ltd R P Pharmaceutical products
US20020197321A1 (en) * 1997-10-27 2002-12-26 Harry Seager Solid dispersing vaccine composition for oral delivery
PL194804B1 (pl) 1998-03-16 2007-07-31 Alk Abello As Zrekombinowany alergen, sposób przygotowywania zrekombinowanego alergenu, kompozycja farmaceutyczna oraz zastosowanie zrekombinowanego alergenu do przygotowywania leku do wywoływania odpowiedzi immunologicznej u osobnika i do przygotowywania leku do leczenia, zapobiegania lub osłabiania reakcji alergicznych
GB9819484D0 (en) * 1998-09-07 1998-10-28 Univ Bristol Therapeutic agents
GB9901819D0 (en) * 1999-01-27 1999-03-17 Scherer Corp R P Pharmaceutical compositions
FR2790387B1 (fr) 1999-03-01 2001-05-18 Prographarm Laboratoires Comprime orodispersible presentant une faible friabilite et son procede de preparation
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
SE9901857D0 (sv) * 1999-05-21 1999-05-21 Anders Cedergren Karl Fischer reagent
AU4139801A (en) 1999-12-06 2001-06-12 Board Of Trustees Of The University Of Arkansas, The Controlled delivery of antigens
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
GB0002386D0 (en) * 2000-02-02 2000-03-22 Novartis Nutrition Ag Therapeutic composition
US6458968B2 (en) * 2000-06-09 2002-10-01 Rensselaer Polytechnic Institute Dithiocarboxylic ester synthetic process
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
ATE414773T1 (de) 2000-11-16 2008-12-15 Alk Abello As Mutante allergene
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
GB2378383A (en) 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
DE10137232A1 (de) * 2001-07-30 2003-02-20 Pierre Foss Allergenträger
CN1668737A (zh) 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
US8012505B2 (en) * 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
DE202008006598U1 (de) * 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung

Also Published As

Publication number Publication date
EP2436395A3 (en) 2012-06-20
WO2004047794A3 (en) 2004-09-16
KR20050103187A (ko) 2005-10-27
WO2004047793A1 (en) 2004-06-10
MXPA05005528A (es) 2006-04-05
CN101816787A (zh) 2010-09-01
AU2010200798B2 (en) 2012-11-15
US9408805B2 (en) 2016-08-09
CA2507551A1 (en) 2004-06-10
MXPA05005527A (es) 2006-04-05
US20140271722A1 (en) 2014-09-18
BR0316564A (pt) 2005-10-04
HK1087008A1 (zh) 2006-10-06
EP2436395A2 (en) 2012-04-04
AU2003283207C1 (en) 2010-07-29
WO2004047794A2 (en) 2004-06-10
AU2003283207B2 (en) 2009-12-03
AU2003280324A1 (en) 2004-06-18
NZ540850A (en) 2008-11-28
EP1567123A2 (en) 2005-08-31
JP5442924B2 (ja) 2014-03-19
PL377745A1 (pl) 2006-02-20
CO5690534A2 (es) 2006-10-31
AU2003283207A1 (en) 2004-06-18
PL218350B1 (pl) 2014-11-28
JP5622594B2 (ja) 2014-11-12
EP2436395B1 (en) 2017-04-26
US9415015B2 (en) 2016-08-16
IL168733A (en) 2011-01-31
US20040166123A1 (en) 2004-08-26
JP2011093926A (ja) 2011-05-12
US10080719B2 (en) 2018-09-25
US20080193535A1 (en) 2008-08-14
KR20120034767A (ko) 2012-04-12
US10471008B2 (en) 2019-11-12
AU2010200798A1 (en) 2010-03-25
US20160324767A1 (en) 2016-11-10
US20080187558A1 (en) 2008-08-07
JP2006513269A (ja) 2006-04-20
NO20053142L (no) 2005-06-27
US20170367970A1 (en) 2017-12-28
KR101281147B1 (ko) 2013-07-02
US8329196B2 (en) 2012-12-11

Similar Documents

Publication Publication Date Title
IS7894A (is) Skammtaform með ofnæmisvaka
IS7689A (is) Fjölþátta lyfjaskammtaform
DE60330207D1 (de) le
IS2672B (is) Asíþrómýsín lyfjaskammtaform með minni hliðarverkanir
DE60328309D1 (de) Ssigkeiten
DE60332534D1 (de) Chinuclidinamidderivate
EP1489376A4 (en) PRIMER
DE602004017700D1 (de) Transmukosen verabreichung
DE60300967D1 (de) Seilantriebsanordung
DE60207371D1 (de) Stumpfvermahlungsgerät
DE60310919D1 (de) Dosiersystem
DE60305663D1 (de) Kippschirm
DE60315105D1 (de) Ozonisator
DE60326590D1 (de) Tend lamotrigin
DE50311715D1 (de) Weltzeituhr
DK1513861T3 (da) Etonogestrelestere
DE60336494D1 (de) Kompaktlader
DE60309990D1 (de) Schraubbefestigungsstruktur
DE60228135D1 (de) Eifen
DE60326562D1 (de) Seinhibitoren
DE50311317D1 (de) Dosiereinrichtung
DE50309499D1 (de) Librierwerkzeugen
DE50309094D1 (de) Dosiereinrichtung
DE60328497D1 (de) Zugschiffspropeller
DE60336661D1 (de) Molsieb ssz-64